These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 14571629)

  • 1. Do atypical antipsychotic agents have a role in the treatment of depression?
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Oct; 41(10):12-6. PubMed ID: 14571629
    [No Abstract]   [Full Text] [Related]  

  • 2. [Priority for atypical antipsychotic drugs? Current studies clarify the issues].
    Dose M
    Psychiatr Prax; 2007 Jan; 34(1):46-9. PubMed ID: 17265252
    [No Abstract]   [Full Text] [Related]  

  • 3. What's atypical about atypical antipsychotic drugs?
    Meltzer HY
    Curr Opin Pharmacol; 2004 Feb; 4(1):53-7. PubMed ID: 15018839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the findings from the European SOHO study.
    Suarez D; Haro JM
    Expert Rev Neurother; 2008 Jun; 8(6):873-80. PubMed ID: 18505352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications.
    Brugue E; Vieta E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):275-82. PubMed ID: 16876306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
    Vohora D
    Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic treatment of adolescent and child schizophrenia.
    Young CM; Findling RL
    Expert Rev Neurother; 2004 Jan; 4(1):53-60. PubMed ID: 15853615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic safety and efficacy concerns.
    Meyer JM
    J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The case for long-acting antipsychotic agents in the post-CATIE era.
    Nasrallah HA
    Acta Psychiatr Scand; 2007 Apr; 115(4):260-7. PubMed ID: 17355516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: a naturalistic 6-month follow-up study.
    Wittorf A; Sickinger S; Wiedemann G; Klingberg S
    Arch Clin Neuropsychol; 2008 May; 23(3):271-82. PubMed ID: 18272323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do atypical antipsychotic agents cause tardive dyskinesia?
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2004 Oct; 42(10):14-9. PubMed ID: 15540874
    [No Abstract]   [Full Text] [Related]  

  • 14. Schizophrenia therapy: beyond atypical antipsychotics.
    Snyder EM; Murphy MR
    Nat Rev Drug Discov; 2008 Jun; 7(6):471-2. PubMed ID: 18483482
    [No Abstract]   [Full Text] [Related]  

  • 15. In the aftermath of CATIE: how should administrators value atypical antipsychotic medications?
    Luchins DJ
    Adm Policy Ment Health; 2006 Sep; 33(5):541-3. PubMed ID: 16688482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study.
    Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M
    Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating response to antidepressant treatment in depression: a possible role for atypical antipsychotics.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):434; author reply 435-6. PubMed ID: 20060869
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pro and contra: basic precedence of atypical neuroleptics].
    Naber D; Dose M
    Psychiatr Prax; 2005 May; 32(4):163-6. PubMed ID: 15852207
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostics and therapy of depressive symptoms in schizophrenic patients].
    Bottlender R; Hampel H; Sievers M; Möller HJ
    MMW Fortschr Med; 2005 May; 147 Spec No 2():59-62. PubMed ID: 15968875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel consortium to address shortfall in innovative medicines for psychiatric disorders.
    Hughes B
    Nat Rev Drug Discov; 2009 Jul; 8(7):523-4. PubMed ID: 19568273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.